The estimated Net Worth of Mark Douglas Smith is at least $783 Tisíc dollars as of 15 August 2024. Mark Smith owns over 4,000 units of Teladoc Health Inc stock worth over $60,992 and over the last 5 years he sold TDOC stock worth over $502,616. In addition, he makes $219,167 as Independent Director at Teladoc Health Inc.
Sign up
Mark Smith TDOC stock SEC Form 4 insiders trading
Mark has made over 13 trades of the Teladoc Health Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 4,000 units of TDOC stock worth $28,320 on 15 August 2024.
The largest trade he's ever made was exercising 7,000 units of Teladoc Health Inc stock on 18 July 2024 worth over $32,970. On average, Mark trades about 1,518 units every 62 days since 2019. As of 15 August 2024 he still owns at least 8,355 units of Teladoc Health Inc stock.
You can see the complete history of Mark Smith stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mark Smith biography
Dr. Mark Douglas Smith M.D. serves as Independent Director of the Company since October 2018. Dr. Smith is a professor of clinical medicine at the University of California at San Francisco. He is a board-certified internist and maintains a clinical practice in HIV care at San Francisco General Hospital. A nationally recognized care delivery and health policy expert, Dr. Smith served as co-chair of the Guiding Committee of the Health Care Payment Learning and Action Network, a public-private partnership launched by the U.S. Department of Health and Human Services, from 2015 to 2019. The group promotes the transition to value-based payment to improve care quality while lowering costs. From 1996 to 2013, Dr. Smith served as the founding president and CEO of the California Health Care Foundation, an independently endowed philanthropy that works to improve healthcare access and quality for Californians. He helped build the foundation into a nationally recognized leader in delivery system innovation, public reporting of care quality, and applications of new technology in healthcare. Dr. Smith was formerly executive vice president of the Henry J. Kaiser Family Foundation. He was elected to the Institute of Medicine in 2001 and chaired its Committee on the Learning Healthcare System. He serves on the boards of the Institute for Healthcare Improvement and the Commonwealth Fund and is on the editorial board of Health Affairs. Dr. Smith received a bachelor’s degree in Afro-American studies from Harvard College, a medical doctorate from the University of North Carolina at Chapel Hill and a master’s degree in business, with a concentration in health care administration, from the Wharton School at the University of Pennsylvania.
What is the salary of Mark Smith?
As the Independent Director of Teladoc Health Inc, the total compensation of Mark Smith at Teladoc Health Inc is $219,167. There are 16 executives at Teladoc Health Inc getting paid more, with Jason Gorevic having the highest compensation of $7,995,690.
How old is Mark Smith?
Mark Smith is 68, he's been the Independent Director of Teladoc Health Inc since 2018. There are 1 older and 19 younger executives at Teladoc Health Inc. The oldest executive at Teladoc Health Inc is David Shedlarz, 71, who is the Independent Director.
What's Mark Smith's mailing address?
Mark's mailing address filed with the SEC is C/O TELADOC HEALTH, INC.,, 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE, NY, 10577.
Insiders trading at Teladoc Health Inc
Over the last 9 years, insiders at Teladoc Health Inc have traded over $190,385,368 worth of Teladoc Health Inc stock and bought 50,333 units worth $544,816 . The most active insiders traders include Hemant Taneja, Glen Tullman a Jason N Gorevic. On average, Teladoc Health Inc executives and independent directors trade stock every 6 days with the average trade being worth of $111,413. The most recent stock trade was executed by Andrew Turitz on 4 September 2024, trading 20,773 units of TDOC stock currently worth $150,812.
What does Teladoc Health Inc do?
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Ranked best in KLAS for Virtual Care Platforms in 2020, Teladoc Health leverages more than a decade of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals.
What does Teladoc Health Inc's logo look like?
Complete history of Mark Smith stock trades at Jazz Pharmaceuticals plc, Teladoc Health Inc a Phreesia Inc
Teladoc Health Inc executives and stock owners
Teladoc Health Inc executives and other stock owners filed with the SEC include:
-
Jason Gorevic,
Chief Executive Officer, Director -
David Sides,
Chief Operating Officer -
Mala Murthy,
Chief Financial Officer -
Lewis Levy,
Chief Medical Officer -
Stephanie Verstraete,
Chief Marketing Officer -
Adam Vandervoort,
Chief Legal Officer and Secretary -
Jason Nathanial Gorevic,
CEO & Director -
Claus Torp Jensen Ph.D.,
Chief Innovation Officer -
Mala Murthy,
Chief Financial Officer -
Adam Christian Vandervoort,
Chief Legal Officer & Sec. -
Gabriel Cappucci,
Senior Vice President - Finance -
David Snow,
Independent Chairman of the Board -
David Shedlarz,
Independent Director -
Thomas McKinley,
Independent Director -
William Frist,
Independent Director -
Kenneth Paulus,
Independent Director -
Mark Smith,
Independent Director -
Catherine Jacobson,
Independent Director -
Andrew Turitz,
Senior Vice President of Business Development -
Michelle Bucaria,
Chief Human Resource Officer -
Mike Waters,
Chief Operating Officer -
Arnnon Geshuri,
Chief HR Officer -
Andrew Turitz,
Sr. VP of Corp. Devel. -
Courtney Kraemer McLeod,
Director of Communication -
Patrick Thomas Feeley C.F.A., CPA,
VP of Investor Relations -
Richard J. Napolitano,
Sr. VP, Chief Accounting Officer & Controller -
Dr. George Byron Brooks,
Co-Founder -
Stephany Verstraete,
Chief Marketing Officer & Engagement Officer -
James L. Cave,
INTERIM CAO -
Tom Mawhinney,
Director -
Arneek Multani,
Director -
Iii Lp Chp,
10% owner -
Iii Lpchp Iii Management, L...,
-
James K Outland,
Director -
Martin R Felsenthal,
Director -
Michael Goldstein,
Director -
Michael H. King,
Chief Sales Officer -
Peter N. Nieves,
EVP and CRO -
Capital Management Vi, L.L....,
-
Helen Darling,
Director -
Iii Management, L.L.C. Chp,
10% owner -
Dana G Jr. Mead,
Director -
Arnnon Geshuri,
CHIEF PEOPLE OFFICER -
Brian P Mcandrews,
Director -
Mark Hirschhorn,
Executive VP and CFO -
Peter A Mcclennen,
President -
Venture Partners Ii, L.P.Hl...,
-
Karen L Daniel,
Director -
Dgf Associates, Llckpcb Dig...,
-
Vidya Raman Tangella,
CHIEF MEDICAL OFFICER -
Laizer Kornwasser,
Advisor to the CEO -
Christopher Caridi,
Chief Accounting Officer -
Richard J Napolitano,
CHIEF ACCOUNTING OFFICER -
Yulun Wang,
Head of Research & Development -
Hemant Taneja,
Director -
Glen Tullman,
Director -
Christopher Bischoff,
-
Jason Eric Evans,
Director -
Claus Torp Jensen,
CHIEF INNOVATION OFFICER -
Daniel Trencher,
CHIEF STRATEGY OFFICER -
Stephany Verstraete,
CHIEF MARKETING OFFICER -
Michael Willem Waters,
CHIEF OPERATING OFFICER -
Nikolaos P. Nanis,
Chief Technology Officer -
Sandra L Fenwick,
Director -
Charles Iii Divita,
CHIEF EXECUTIVE OFFICER